Somagenetix

Innovative gene therapy for monogenetic diseases

The first gene therapy company in Switzerland dedicated to research, development and application of gene therapeutic products and diagnostics in humans.

  • Ready-to-use gene therapy vector CGD with high preclinical safety and efficacy
  • Ready-to-use diagnostic tool for gene therapy monitoring
  • Gene vehicle platform established, ready-to-use for a variety of target gene defects

Team

  • Janine Reichenbach, project leader
  • Ulrich Siler, scientific lead
  • Oleksandr Pastukhov, technical lead

Contact

Logo